Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01756690 · ClinicalTrials.gov registry record
Predicting Lung Injury From Transfusion in Patients With Liver Disease
A clinical trial, sponsored by University of Colorado, Denver.
- Terminated
- Registry status
- 16
- Enrollment target
NCT01756690 is a clinical trial that was terminated before completion, run by University of Colorado, Denver. The registered enrollment target is 16 participants.
The verdict
NCT01756690 was terminated before completion, sponsored by University of Colorado, Denver.
- TERMINATED
- Registry status
- 16 participants
- Enrollment target
Study Summary
A certain molecule floating in the blood may represent a risk of lung injury after a transfusion. We are determining whether detection of this molecule on a simple blood clotting test will predict the development of lung injury due to transfusion in bleeding patients with chronic liver disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2011-10 |
| Est. Completion | 2016-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01756690
The ClinicalTrials.gov registry entry for NCT01756690 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01756690 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01756690 about?
NCT01756690 is a clinical study titled "Predicting Lung Injury From Transfusion in Patients With Liver Disease". A certain molecule floating in the blood may represent a risk of lung injury after a transfusion. We are determining whether detection of this molecule on a simple blood clotting test will predict the development of lung injury due to transfusion in bleeding patients with chronic liver disease.
What is the current status of trial NCT01756690?
This trial is currently terminated. The enrollment target is 16 participants. The study started on 2011-10. Estimated completion is 2016-12.
Who is sponsoring clinical trial NCT01756690?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.